Acumen Pharmaceuticals Cash Flow Statement (2020-2026) | ABOS

Cash Flow Statement Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
-55.06M-3.92M-8.39M-9.24M-22.91M-51.19M-14.13M-13.18M-11.63M-12.91M-14.70M-14.77M-21.57M-29.79M-36.55M-28.92M-40.78M-25.94M-24.96M-21.15M
Depreciation and Depletion (Quarter)
0.00M0.00M0.01M0.01M0.01M0.01M0.01M0.01M0.02M0.02M0.02M0.02M0.01M0.01M0.02M0.01M0.01M0.01M
Share-based Compensation (Quarter)
0.13M0.30M-0.56M0.62M-0.39M2.83M2.91M-2.91M6.14M2.48M-2.45M7.26M2.34M0.07M4.90M-4.90M2.40M
Asset Writedowns and Impairment (Quarter)
0.00M
Cash from Operations (Quarter)
-4.26M-7.69M-3.64M-8.30M-6.47M-9.18M-11.20M-10.18M-11.67M-12.90M-8.31M-17.86M-16.55M-24.60M-27.21M-34.12M-31.83M-30.49M-19.10M-24.13M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
-0.16M-0.22M-0.17M-0.19M0.09M0.33M0.30M0.71M1.78M1.76M1.46M1.38M0.42M0.59M0.06M0.28M-0.11M-0.03M
Amortization of Deferred Charges (Quarter)
0.03M0.03M0.03M0.04M0.04M0.04M0.03M0.02M0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.03M
Depreciation & Amortization (CF) (Quarter)
0.00M0.00M0.01M0.01M0.01M0.01M0.01M0.01M0.02M0.02M0.02M0.02M0.01M0.01M0.02M0.01M0.01M0.01M
Change in Working Capital
Change in Account Payables (Quarter)
0.35M-0.89M0.71M0.12M0.46M0.42M-0.44M-0.88M1.26M-0.66M0.02M1.70M1.12M-1.86M3.31M-4.59M1.05M-1.42M-0.13M1.05M
Change in Accured Expenses (Quarter)
-0.26M-0.01M2.80M-1.76M0.33M0.37M0.50M-0.60M-0.41M0.83M3.06M-3.53M1.15M0.89M1.52M0.06M4.90M-3.90M2.23M-5.04M
Other Working Capital Changes (Quarter)
-0.03M-0.03M-0.03M-0.04M-0.04M-0.04M-0.03M-0.01M-0.02M-0.03M-0.03M
Investing Activities
Capital Expenditures (Quarter)
0.01M0.03M0.01M0.03M0.08M0.04M0.01M0.01M0.01M0.01M0.08M0.01M
Change in Acquisitions & Divestments (Quarter)
4.00M11.86M56.00M9.00M10.20M11.06M34.73M22.98M36.10M49.51M88.41M44.76M63.82M41.50M40.51M26.25M27.02M
Cash from Investing Activities (Quarter)
-94.10M-10.01M-5.10M8.79M55.92M-20.42M-41.93M11.06M-92.00M-48.81M-9.20M37.70M-10.13M29.66M28.69M38.48M40.51M26.25M-13.81M
Financing Activities
Other financing activities (Quarter)
-1.25M0.61M0.00M-0.02M0.33M0.15M0.04M0.00M0.14M
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter)
138.53M-0.00M3.79M122.29M-0.39M7.94M
Misc.
Cash from Financing Activities (Quarter)
168.78M0.01M-0.26M4.18M-0.14M122.76M29.13M7.11M-0.13M-0.04M-0.01M-0.04M0.00M35.74M
Change in Cash (Quarter)
27.41M66.99M-13.64M-13.40M2.30M46.47M-27.44M-52.10M-0.75M17.86M-27.99M-19.95M21.03M-34.77M2.44M-5.47M6.65M10.02M7.16M-2.19M
Free Cash Flow (Quarter)
-4.26M-7.70M-3.67M-8.31M-6.50M-9.27M-11.24M-10.18M-11.67M-12.91M-8.33M-17.87M-16.55M-24.60M-27.21M-34.20M-31.84M-30.49M-19.10M-24.13M
Net Cash Flow (Quarter)
-4.26M66.99M-13.64M-13.40M2.32M46.47M-27.44M-52.10M-0.75M17.86M-27.99M-19.95M21.03M-34.77M2.44M-5.47M6.65M10.02M7.16M-2.19M